Features of the etythropoesis upon treatment of chronic myeloid leukemia with tyrosine kinase inhibitor
A functional activity of erythroid hematopoietic cells of patients with chronic myeloid leukemia, who were treated with tyrosine kinase inhibitor of the first and second generation was investigated. Samples of bone marrow of patients with resistance to tyrosine kinase inhibitor treatment show an inc...
Main Authors: | I. Sviezhentseva, D. Bilko, N. Bilko, I. Dyagil |
---|---|
Format: | Article |
Language: | English |
Published: |
Taras Shevchenko National University of Kyiv
2016-07-01
|
Series: | Vìsnik: Kiïvsʹkij Nacìonalʹnij Unìversitet Imenì Tarasa Ševčenka. Bìologìâ |
Subjects: | |
Online Access: | http://biovestnik.com/index.php/biology/article/view/30 |
Similar Items
-
Comparative evaluation of bone marrow cells morpho-functional activity in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors of the first and second generation
by: I. O. Zhaleyko, et al.
Published: (2014-07-01) -
The Mechanisms of Resistance to Tyrosine Kinase Inhibitor Imatinib Therapy of Chronic Myeloid Leukemia
by: S. I. Kutsev, et al.
Published: (2010-06-01) -
WHO 2016 Definition of Chronic Myeloid Leukemia and Tyrosine Kinase Inhibitors
by: İbrahim C. Haznedaroğlu, et al.
Published: (2020-02-01) -
Tyrosine kinase inhibitors induced immune thrombocytopenia in chronic myeloid leukemia?
by: Avital F. Barak, et al.
Published: (2011-12-01) -
Gold nanoparticles enhance the effect of tyrosine kinase inhibitors in acute myeloid leukemia therapy
by: Petrushev B, et al.
Published: (2016-02-01)